{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:01:08Z","timestamp":1753891268054,"version":"3.41.2"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate histologic features of immunological components in the primary tumor site of patients with cancer-associated myositis (CAM) by focusing on tumor-infiltrating lymphocytes (TILs) and tertiary lymphoid structures (TLSs), which play major roles in antitumor immunity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Cancer-associated myositis patients were selected from the single-center idiopathic inflammatory myopathy cohort based on the availability of primary tumor specimens obtained before the introduction of immunomodulatory agents. Control cancer subjects without CAM were selected from the cancer tissue repository at a ratio of 1:2 matched for demographics and cancer characteristics of CAM cases. A series of immunohistochemical analyses was conducted using sequential tumor sections. TLS was defined as an ectopic lymphoid-like structure composed of DC-LAMP<jats:sup>+<\/jats:sup> mature dendritic cells, CD23<jats:sup>+<\/jats:sup> follicular dendritic cells (FDCs) and PNAd<jats:sup>+<\/jats:sup> high endothelial venules. TLS distribution was classified into the tumor center, invasive margin, and peritumoral area.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Six CAM patients and 12 matched non-CAM controls were eligible for the study. There was no apparent difference in the density or distribution of TILs between the groups. TLSs were found in 3 CAM patients (50%) and 4 non-CAM controls (33%). TLSs were exclusively located at the tumor center or invasive margin in CAM cases but were mainly found in the peritumoral area in non-CAM controls. FDCs and class-switched B cells colocalized with follicular helper T cells were abundantly found in the germinal center-like area of TLSs from CAM patients compared with those from non-CAM controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The adaptive immune response within TLSs in the primary tumor site might contribute to the pathogenic process of CAM.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.1066858","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T14:18:41Z","timestamp":1672841921000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Tertiary lymphoid structures in the primary tumor site of patients with cancer-associated myositis: A case\u2013control study"],"prefix":"10.3389","volume":"9","author":[{"given":"Hiroko","family":"Kadota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Gono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Kunugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Takeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Seike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Kuwana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrrheum.2018.41","article-title":"Classification of myositis.","volume":"14","author":"Lundberg","year":"2018","journal-title":"Nat Rev Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/bjd.15607","article-title":"The pathogenesis of dermatomyositis.","volume":"179","author":"Thompson","year":"2018","journal-title":"Br J Dermatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1172\/JCI78084","article-title":"Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity.","volume":"125","author":"Suurmond","year":"2015","journal-title":"J Clin Invest."},{"key":"B4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3899\/jrheum.140566","article-title":"Polymyositis\/dermatomyositis and malignancy risk: a metaanalysis study.","volume":"42","author":"Yang","year":"2015","journal-title":"J Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/1203475416665601","article-title":"Risk of malignancy in dermatomyositis and polymyositis: a systematic review and meta-analysis.","volume":"21","author":"Qiang","year":"2017","journal-title":"J Cutan Med Surg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine (Baltimore)."},{"key":"B7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/art.33379","article-title":"Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis.","volume":"64","author":"Trallero-Araguas","year":"2012","journal-title":"Arhritis Rheum."},{"key":"B8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/BOR.0000000000000641","article-title":"The role of cancer-associated autoantibodies as biomarkers in paraneoplastic myositis syndrome.","volume":"31","author":"Lu","year":"2019","journal-title":"Curr Opin Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1158\/2159-8290.CD-20-1680","article-title":"The next decade of immune checkpoint therapy.","volume":"11","author":"Sharma","year":"2021","journal-title":"Cancer Discov."},{"key":"B10","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41423-020-00565-9","article-title":"Tumor-infiltrating lymphocytes in the immunotherapy era.","volume":"18","author":"Paijens","year":"2021","journal-title":"Cell Mol Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1172\/JCI67428","article-title":"CD4+ follicular helper T cell infiltration predicts breast cancer survival.","volume":"123","author":"Gu-Trantien","year":"2013","journal-title":"J Clin Invest."},{"key":"B12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.it.2012.04.006","article-title":"Tertiary lymphoid organs in infection and autoimmunity.","volume":"33","author":"Neyt","year":"2012","journal-title":"Trends Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy.","volume":"19","author":"Saut\u00e8s-Fridman","year":"2019","journal-title":"Nat Rev Cancer."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer.","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/art.40320","article-title":"2017 European league against rheumatism\/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.21873\/anticanres.11696","article-title":"RT-PCR for detecting ALK translocations in cytology samples from lung cancer patients.","volume":"37","author":"Nakamichi","year":"2017","journal-title":"Anticancer Res."},{"journal-title":"TNM Classification of Malignant Tumours.","year":"2017","author":"Brierley","key":"B17"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roac056","article-title":"A multianalyte assay for the detection of dermatomyositis-related autoantibodies based on immunoprecipitation combined with immunoblotting.","author":"Kuwana","year":"2022","journal-title":"Mod Rheumatol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060442","article-title":"Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.","volume":"8","author":"Hamaguchi","year":"2013","journal-title":"PLoS One."},{"key":"B20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/14397595.2018.1452179","article-title":"Improved quantification of a commercial enzyme-linked immunosorbent assay kit for measuring anti-MDA5 antibody.","volume":"29","author":"Gono","year":"2019","journal-title":"Mod Rheumatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/bs.mcb.2019.11.024","article-title":"Histochemical and immunohistochemical staining methods to visualize mitochondrial proteins and activity.","volume":"155","author":"Franco-Iborra","year":"2020","journal-title":"Methods Cell Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3892\/ijo.20.5.943","article-title":"Expression and accumulation of lumican protein in uterine cervical cancer cells at the periphery of cancer nests.","volume":"20","author":"Naito","year":"2002","journal-title":"Int J Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"9512","DOI":"10.3892\/mmr.2017.7780","article-title":"Frequency and distribution of CD4+CXCR5+ follicular B helper T cells within involved tissues in IgG4-related ophthalmic disease.","volume":"16","author":"Yang","year":"2017","journal-title":"Mol Med Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/his.14108","article-title":"Computerised scoring protocol for identification and quantification of different immune cell populations in breast tumour regions by the use of QuPath software.","volume":"77","author":"Berben","year":"2020","journal-title":"Histopathology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/PAP.0000000000000162","article-title":"Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology biomarkers working group: part 1: assessing the host immune response, TILs in invasive breast carcinoma and ductal carcinoma in situ, metastatic tumor deposits and areas for further research.","volume":"24","author":"Hendry","year":"2017","journal-title":"Adv Anat Pathol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.it.2014.09.006","article-title":"Tertiary lymphoid structures in cancer and beyond.","volume":"35","author":"Dieu-Nosjean","year":"2014","journal-title":"Trends Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"432","DOI":"10.4049\/jimmunol.1701269","article-title":"Immune cell infiltration and tertiary lymphoid structures as determinants of antitumor immunity.","volume":"200","author":"Engelhard","year":"2018","journal-title":"J Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-1-4939-8709-2_4","article-title":"Development of tools for the selective visualization and quantification of TLS-immune cells on tissue sections.","volume":"1845","author":"Klein","year":"2018","journal-title":"Methods Mol Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","article-title":"B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome.","volume":"19","author":"Fridman","year":"2022","journal-title":"Nat Rev Clin Oncol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41423-020-0457-0","article-title":"Tertiary lymphoid structures in cancer - considerations for patient prognosis.","volume":"17","author":"Munoz-Erazo","year":"2020","journal-title":"Cell Mol Immunol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1900508","article-title":"Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies.","volume":"10","author":"Jacquelot","year":"2021","journal-title":"Oncoimmunology."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.18632\/aging.102821","article-title":"Existence of intratumoral tertiary lymphoid structures is associated with immune cells infiltration and predicts better prognosis in early-stage hepatocellular carcinoma.","volume":"12","author":"Li","year":"2020","journal-title":"Aging (Albany NY)."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.648812","article-title":"Peritumoral tertiary lymphoid structures correlate with protective immunity and improved prognosis in patients with hepatocellular carcinoma.","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00244","article-title":"Tertiary lymphoid organs in cancer tissues.","volume":"7","author":"Hiraoka","year":"2016","journal-title":"Front Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1158\/1078-0432.CCR-15-2762","article-title":"Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer.","volume":"22","author":"Kroeger","year":"2016","journal-title":"Clin Cancer Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response.","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2020.112753","article-title":"T follicular helper and T follicular regulatory cells in colorectal cancer: a complex interplay.","volume":"480","author":"Hetta","year":"2020","journal-title":"J Immunol Methods."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.91487","article-title":"CXCL13-producing Tfh cells link immune suppression and adaptive memory in human breast cancer.","volume":"2","author":"Gu-Trantien","year":"2017","journal-title":"JCI Insight."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1016646","article-title":"Mechanism and strategies of immunotherapy resistance in colorectal cancer.","volume":"13","author":"Shan","year":"2022","journal-title":"Front Immunol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1257452","article-title":"Tumor-infiltrating lymphocyte composition, organization and PD-1\/ PD-L1 expression are linked in breast cancer.","volume":"6","author":"Buisseret","year":"2016","journal-title":"Oncoimmunology."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1378844","article-title":"Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer.","volume":"7","author":"Posch","year":"2017","journal-title":"Oncoimmunology."},{"key":"B42","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2340\/00015555-3091","article-title":"Use of anti- transcriptional intermediary factor-1 gamma autoantibody in identifying adult dermatomyositis patients with cancer: a systematic review and meta-analysis.","volume":"99","author":"Best","year":"2019","journal-title":"Acta Derm Venereol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/rheumatology\/kex413","article-title":"Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis.","volume":"57","author":"Pinal-Fernandez","year":"2018","journal-title":"Rheumatology (Oxford)."},{"key":"B44","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1084\/jem.20041367","article-title":"Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy.","volume":"201","author":"Casciola-Rosen","year":"2005","journal-title":"J Exp Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/rheumatology\/kez572","article-title":"Anti-TIF1-\u03b3 autoantibodies: warning lights of a tumour autoantigen.","volume":"59","author":"De Vooght","year":"2020","journal-title":"Rheumatology (Oxford)."},{"key":"B46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrrheum.2016.217","article-title":"Ectopic lymphoid neogenesis in rheumatic autoimmune diseases.","volume":"13","author":"Bombardieri","year":"2017","journal-title":"Nat Rev Rheumatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jbspin.2018.03.001","article-title":"Air pollution as a determinant of rheumatoid arthritis.","volume":"86","author":"Sigaux","year":"2019","journal-title":"Joint Bone Spine."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1172\/JCI28756","article-title":"Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis.","volume":"116","author":"Rangel-Moreno","year":"2006","journal-title":"J Clin Invest."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000451","article-title":"Architectural B-cell organization in skeletal muscle identifies subtypes of dermatomyositis.","volume":"5","author":"Radke","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1066858\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T14:18:44Z","timestamp":1672841924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1066858\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":49,"alternative-id":["10.3389\/fmed.2022.1066858"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1066858","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"article-number":"1066858"}}